PRLD

Prelude Therapeutics Inc

4.095

+0.435+11.89%

Opening11:47 06/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.660/3.660

TODAY RANGE3.610-4.168

VOL171.72K

MARKET CAP326.15M

52 WEEK RANGE0.7500-5.54

AVG VOL (3M)383.93K

% TURNOVER0.22%

TURNOVER--

P/E (TTM)-4.0852

% RANGE15.25%

EPS(TTM)-1.0024

P/E(FORWARD)-17.8043

P/B4.288

BVPS0.9550

DIVIDEND--

P/S21.24

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP180.80M

SHARES OUTSTANDING79.65M

NEXT EARNINGS08/12-08/17

FREE FLOAT44.15M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·05/15 09:13
Prelude Therapeutics initiated with Early-Stage Biotech at Goldman Sachs
TipRanks·05/12 12:04
Prelude Therapeutics Launches Phase 1 Trial and Extends Runway
Seeking Alpha·05/12 11:34
Prelude Therapeutics GAAP EPS of -$0.13 beats by $0.12, revenue of $4.58M
Reuters·05/12 11:13
Prelude Therapeutics Q1 net loss narrows as expenses fall
Dow Jones·05/12 11:02
*Prelude Therapeutics 1Q Rev $4.58M >PRLD
Dow Jones·05/12 11:02
*Prelude Therapeutics: Current Cash Runway Into 2Q 2028 >PRLD
Reuters·05/12 11:01
PRELUDE THERAPEUTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Dow Jones·05/12 11:01
*Prelude Therapeutics 1Q Loss $10.4M >PRLD
Dow Jones·05/04 14:08
Prelude Therapeutics Price Target Announced at $9.00/Share by D. Boral Capital
Dow Jones·05/04 14:08
Prelude Therapeutics Initiated at Buy by D. Boral Capital
TipRanks·05/04 11:35
Prelude Therapeutics initiated with a Buy at D. Boral Capital
TipRanks·05/02 16:30
Prelude Therapeutics Advances First‑in‑Human PRT12396 Trial in High‑Risk Blood Cancers
PUBT·04/28 21:24
Prelude Therapeutics initial beneficial ownership statement names RA Capital Management
Dow Jones·04/27 12:08
Prelude Therapeutics Price Target Raised to $8.00/Share From $5.00 by HC Wainwright & Co.
Dow Jones·04/27 12:08
Prelude Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Same Industry

Name/Symbol

Change%

Price

Prelude Therapeutics Inc

PRLD

+11.89%

4.095

REGN

GRDX

BIONTECH

BNTX

+2.69%

95.95

United Therapeutics Corp.

UTHR

-0.94%

556.82

Vertex Pharmaceuticals Inc

VRTX

-0.10%

447.54

SIGA

Moderna

MRNA

-0.80%

47.19

Charles Riv Labs Intl Inc

CRL

-0.35%

180.71

MEDP

TLPH

ICON plc

ICLR

-0.53%

136.07

CBPO

IQV

MOLECULAR PARTNERS AG

MOLN

+4.92%

4.200

ARCT

GILD

PRAH

Incyte Corp

INCY

-0.78%

96.74

Aptevo Therapeutics Inc

APVO

-1.91%

5.14

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.